The Current Ratio as of November 2024 (TTM) for Bellerophon Therapeutics, Inc. (BLPH) is 3.96

According to Bellerophon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.96. This represents a change of 53.88% compared to the average of 2.58 of the last 4 quarters.

Bellerophon Therapeutics, Inc. (BLPH) Historical Current Ratio (quarterly & annually)

How has BLPH Current Ratio performed in the past?

The mean historical Current Ratio of Bellerophon Therapeutics, Inc. over the last ten years is 3.02. The current 3.96 Current Ratio has changed 13.01% with respect to the historical average. Over the past ten years (40 quarters), BLPH's Current Ratio was at its highest in in the June 2020 quarter at 9.17. The Current Ratio was at its lowest in in the March 2014 quarter at 0.

Bellerophon Therapeutics, Inc. (BLPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bellerophon Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bellerophon Therapeutics, Inc. (BLPH) Average Current Ratio

How has BLPH Current Ratio performed in the past?

The current Current Ratio of Bellerophon Therapeutics, Inc. (BLPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bellerophon Therapeutics, Inc. (BLPH) Current Ratio vs. Peers

How is BLPH’s Current Ratio compared to its peers?

Bellerophon Therapeutics, Inc.’s Current Ratio is less than Bio-Path Holdings, Inc. (0), greater than Catalyst Biosciences, Inc. (1.67), greater than Diffusion Pharmaceuticals Inc. (0), less than Capricor Therapeutics, Inc. (10.96), greater than NextCure, Inc. (1.37), less than Zura Bio Limited (8.35), less than Altamira Therapeutics Ltd. (12.57), greater than Immix Biopharma, Inc. (1.38), less than Enveric Biosciences, Inc. (7.00), less than Palisade Bio, Inc. (7.37), less than null (4.31),

Build a custom stock screener for Bellerophon Therapeutics, Inc. (BLPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellerophon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bellerophon Therapeutics, Inc. (BLPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bellerophon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.